Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Clinical trial NCT00481065 · COMPLETED

Trial details

NCT number: NCT00481065
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pandemic Avian Influenza

Start date: 2007-04-01
Primary completion: 2008-12-01
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.